Cloud Alpha Capital Management Limited Iovance Biotherapeutics, Inc. Transaction History
Cloud Alpha Capital Management Limited
- $1.68 Billion
- Q3 2024
A detailed history of Cloud Alpha Capital Management Limited transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Cloud Alpha Capital Management Limited holds 1,000,000 shares of IOVA stock, worth $11.7 Million. This represents 3.12% of its overall portfolio holdings.
Number of Shares
1,000,000Holding current value
$11.7 Million% of portfolio
3.12%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding IOVA
# of Institutions
318Shares Held
240MCall Options Held
1.27MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA26MShares$303 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY25.9MShares$302 Million6.02% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$280 Million28.39% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$247 Million0.0% of portfolio
-
State Street Corp Boston, MA12.6MShares$147 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.84B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...